About P-Cure
P-Cure is a company based in Lod (Israel) founded in 2007 by Michael Marash. It operates as a HealthTech. P-Cure has raised $15 million across 1 funding round. P-Cure offers products and services including Gantry-Less Proton Therapy System. P-Cure operates in a competitive market with competitors including Advanced Oncotherapy, Terapet, B dot Medical, HIL Medical and Provision Healthcare, among others.
- Headquarter Lod, Israel
- Founders Michael Marash
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name P-Cure Ltd.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$15 M (USD)
in 1 rounds
-
Latest Funding Round
$15 M (USD), Series B
Jul 16, 2019
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of P-Cure
P-Cure offers a comprehensive portfolio of products and services, including Gantry-Less Proton Therapy System. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Compact proton therapy system for cancer treatment provided.
Unlock access to complete
Funding Insights of P-Cure
P-Cure has successfully raised a total of $15M through 1 strategic funding round. The most recent funding activity was a Series B round of $15 million completed in July 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series B — $15.0M
-
First Round
First Round
(16 Jul 2019)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2019 | Amount | Series B - P-Cure | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by P-Cure
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - P-Cure
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
P-Cure Comparisons
Competitors of P-Cure
P-Cure operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Advanced Oncotherapy, Terapet, B dot Medical, HIL Medical and Provision Healthcare, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of proton beam therapy system for the treatment of cancer
|
|
| domain | founded_year | HQ Location |
Terapet is focused on developing imaging solutions for proton therapy.
|
|
| domain | founded_year | HQ Location |
Proton beam therapeutic devices for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Proton-beam radiotherapy devices are developed for solid tumor treatment.
|
|
| domain | founded_year | HQ Location |
Proton therapy system for cancer treatment is developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on P-Cure
Frequently Asked Questions about P-Cure
When was P-Cure founded?
P-Cure was founded in 2007 and raised its 1st funding round 12 years after it was founded.
Where is P-Cure located?
P-Cure is headquartered in Lod, Israel. It is registered at Lod, Central District, Israel.
Who is the current CEO of P-Cure?
Michael Marash is the current CEO of P-Cure. They have also founded this company.
Is P-Cure a funded company?
P-Cure is a funded company, having raised a total of $15M across 1 funding round to date. The company's 1st funding round was a Series B of $15M, raised on Jul 16, 2019.
What does P-Cure do?
P-Cure is engaged in the development and supply of compact proton therapy systems for cancer treatment. The company operates within the healthcare sector, focusing on medical devices for radiation therapy. Solutions are designed to fit existing linac-like vaults, offering treatment in both seated and supine positions. Operations are supported globally with platforms in the US, Israel, and China, ensuring accessibility and cost efficiency for oncology centers. Collaboration with healthcare providers is emphasized to achieve rapid return on investment.
Who are the top competitors of P-Cure?
P-Cure's top competitors include Advanced Oncotherapy, Terapet and HIL Medical.
What products or services does P-Cure offer?
P-Cure offers Gantry-Less Proton Therapy System.